Relapsed or Refractory Acute Leukemia
3 clinical trials · Condition
◉ Watch Relapsed or Refractory Acute Leukemia
| Record | Firm | Date |
|---|---|---|
| Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia (NCT03672851) | Second Affiliated Hospital of Xi'an Jiaotong University | 2019-04-17 |
Track Relapsed or Refractory Acute Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.